Differential effects of chloroquine on cardiolipin biosynthesis in hepatocytes and H9c2 cardiac cells.
Chloroquine is a potent lysomotropic therapeutic agent used in the treatment of malaria. The mechanism of the chloroquine-mediated modulation of new cardiolipin biosynthesis in isolated rat liver hepatocytes and H9c2 cardiac myoblast cells was addressed in this study. Hepatocytes or H9c2 cells were incubated with [1,3-(3)H]glycerol in the absence or presence of chloroquine and cardiolipin biosynthesis was examined. The presence of chloroquine in the incubation medium of hepatocytes resulted in a rapid accumulation of radioactivity in cardiolipin indicating an elevated de novo biosynthesis. In contrast, chloroquine caused a reduction in radioactivity incorporated into cardiolipin in H9c2 cells. The presence of brefeldin A, colchicine or 3-methyladenine did not effect radioactivity incorporated into cardiolipin nor the chloroquine-mediated stimulation of cardiolipin biosynthesis in hepatocytes indicating that vesicular transport, cytoskeletal elements or increased autophagy were not involved in de novo cardiolipin biosynthesis induced by chloroquine. The addition of chloroquine to isolated rat liver membrane fractions did not affect the activity of the enzymes of de novo cardiolipin biosynthesis but resulted in an inhibition of mitochondrial cytidine-5'-diphosphate-1,2-diacyl-sn-glycerol hydrolase activity. The mechanism for the reduction in cardiolipin biosynthesis in H9c2 cells was a chloroquine-mediated inhibition of glycerol uptake and this did not involve impairment of lysosomal function. The kinetics of the chloroquine-mediated inhibition of glycerol uptake indicated the presence of a glycerol transporter in H9c2 cells. The results of this study clearly indicate that chloroquine has markedly different effects on glycerol uptake and cardiolipin biosynthesis in hepatocytes and H9c2 cardiac cells.
Ross
T K
TK
Department of Biochemistry and Molecular Biology, University of Manitoba, Winnipeg, Canada.
Xu
F Y
FY
Taylor
W A
WA
Hatch
G M
GM
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D002308:Cardiolipins / Q000096:biosynthesis*; D002460:Cell Line; D002462:Cell Membrane; D002478:Cells, Cultured; D002738:Chloroquine / Q000494:pharmacology*; D002999:Clone Cells; D005990:Glycerol / Q000378:metabolism; D006321:Heart / Q000187:drug effects*; D007700:Kinetics; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D051381:Rats
D000962:Antimalarials; D002308:Cardiolipins; D008055:Lipids; D002738:Chloroquine; D005990:Glycerol